EP3331392B1 - Orthetische vorrichtung für schuhe - Google Patents

Orthetische vorrichtung für schuhe Download PDF

Info

Publication number
EP3331392B1
EP3331392B1 EP16831985.3A EP16831985A EP3331392B1 EP 3331392 B1 EP3331392 B1 EP 3331392B1 EP 16831985 A EP16831985 A EP 16831985A EP 3331392 B1 EP3331392 B1 EP 3331392B1
Authority
EP
European Patent Office
Prior art keywords
lateral
foot
orthotic device
medial
valgus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP16831985.3A
Other languages
English (en)
French (fr)
Other versions
EP3331392A1 (de
EP3331392A4 (de
Inventor
Emily SALKAVICH
Nigel Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayfarer Co Pty Ltd
Original Assignee
Wayfarer Co Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2015903126A external-priority patent/AU2015903126A0/en
Application filed by Wayfarer Co Pty Ltd filed Critical Wayfarer Co Pty Ltd
Publication of EP3331392A1 publication Critical patent/EP3331392A1/de
Publication of EP3331392A4 publication Critical patent/EP3331392A4/de
Application granted granted Critical
Publication of EP3331392B1 publication Critical patent/EP3331392B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
    • A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
    • A43B7/142—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the medial arch, i.e. under the navicular or cuneiform bones
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B17/00—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined
    • A43B17/02—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined wedge-like or resilient
    • A43B17/023—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined wedge-like or resilient wedge-like
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
    • A43B7/141—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form having an anatomical or curved form
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
    • A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
    • A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
    • A43B7/143—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the lateral arch, i.e. the cuboid bone
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
    • A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
    • A43B7/144—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the heel, i.e. the calcaneus bone
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
    • A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
    • A43B7/1445—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the midfoot, i.e. the second, third or fourth metatarsal
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/24—Insertions or other supports preventing the foot canting to one side , preventing supination or pronation

Definitions

  • the present invention relates to an orthotic device as specified in claim 1 and a method of fitting an orthotic device as specified in claim 8. Preferred embodiments are specified in the dependent claims.
  • Foot orthotic devices also known as orthoses
  • foot orthotic devices are commonly prescribed by health professionals to alter foot kinetics, improve function, provide cushioning, reduce pain, prevent injury and redistribute forces acting upon the lower limb musculoskeletal system.
  • Foot orthotic devices may be made to an individual's customized prescription or manufactured for the mass population and are usually designed specifically for a certain type of footwear including running shoes, work shoes and high heels.
  • a customised orthotic prescription is made from an impression of the individual's foot and manufactured to a personalised prescription fitting the morphology of the individual's foot.
  • an off-the-shelf orthotic also known as a generic orthotic/orthoses
  • High heels are worn, generally by women, to achieve an appealing posture, height gain and to accompany an outfit.
  • modification of walking gait is required to accommodate the pitched heel, such that the higher the heel pitch, more accentuated biomechanical changes occur.
  • heeled shoes are defined as any shoe with a heel to toe vertical difference (heel pitch) greater than 30mm, with the heel raised higher than the forefoot.
  • the wearer has to actively accommodate for the heel height in contact, stance and swing phases of gait through musculoskeletal compensations at the foot, ankle, knees, hips and spine including a change of the wearer's center of mass, forward trunk lean, forward positioning of the chest, shorter stride length, the buttock protrudes, significant increase in pressure loading though the forefoot, increased rigidity through the arch of the foot, reduced shock absorption, shortened calf muscle length and altered muscle activation of the lower limb and spine.
  • heel height directly relates to a significant increase in peak pressure of the forefoot.
  • Hicks identified that when passive dorsiflexion is applied to the hallux (i.e. when the heel raises during walking gait) it sequentially initiates the plantar aponeurosis to tighten, followed by the rise of the medial longitudinal arch, the rearfoot inverts and the tibia / fibula complex externally rotates. This is known as the "windlass mechanism".
  • Orthoses that concentrate support on the medial arch and/or medial foot including a varus wedge will amplify over-supination, contributing further instability and associated pathologies when used in heeled shoes.
  • the design can be utilized by persons requiring support of their lateral foot in flat shoes and / or sport shoes, particularly a person who has a high arched foot, a person who suffers with chronic ankle instability or a person suffering with acute strain or overuse of the lateral leg musculature.
  • the invention may also be appropriate for persons with medial knee arthritic degeneration or persons who excessively wear the lateral outsole of their shoes.
  • US 2011/0083345 discloses an orthotic device used for controlling motion of a human foot.
  • the present invention provides an orthotic device for use with a flat, sport, dress or heeled shoe, according to the appended claim 1. Further embodiments of the orthotic device are defined by the dependent claims 2-7.
  • the valgus wedge preferably extends along the lateral border of the orthotic device from the rearfoot portion to the forefoot portion.
  • the valgus wedge is preferably angled at about 7 degrees (approx. 4.5mm in vertical height) relative to the body portion however this measurement may be increased or decreased depending on the purpose of the device and may measure up to 20mm where the lateral border is vertically higher compared with the medial border of the device.
  • the valgus wedge is preferably an internally fixed lateral skive.
  • the orthotic device further may comprise of a lateral arch defined by a projection extending away from the body portion vertically, the lateral arch being highest at a lateral portion of the device, and adapted to be located generally under a cuboid bone of a user's foot.
  • the orthotic device further may comprise of a metatarsal bar.
  • the present invention provides a method of fitting an orthotic device to a shoe, according to the appended claim 8. Further embodiments of the method of fitting an orthotic device to a shoe are defined by the dependent claims 9 and 10.
  • An example not part of the present invention provides a design platform for modification to the design of the shank or insole of a high heel and may be integrated directly to the shoe during the manufacturing process.
  • the inventor has conducted a clinical study and preliminary research that links the passive dorsiflexion of the hallux in a heeled shoe with the constant activation of the windlass mechanism causing subtalar joint inversion, foot supination and subsequent lateral instability.
  • the findings of this research directly correlated the supinated foot position with musculoskeletal fatigue and pain associated with wearing high heels.
  • the inventor has applied the innovative findings from the preliminary research to design a unique high heel insole structure that applies an eversion force at the rearfoot, midfoot and forefoot as well as medial arch contour.
  • the eversion force of the insole acts against the supinatory force of the foot, thus minimising the biomechanical complications associated with a heeled shoe (outlined below).
  • the invention also incorporates shock-absorbing material that is of malleable formation throughout the insole structure.
  • the design of the preferred embodiment incorporates a rearfoot, midfoot and forefoot valgus design that assists the foot to withstand the supinatory forces caused by the constant activation of the windlass mechanism and therefore provides lateral foot and ankle stability. This in turn reduces the eccentric load on the lateral ankle stabilisers (both primary and secondary) thus minimising subsequent muscular fatigue, musculoskeletal pain, joint load and biomechanical compensation.
  • a valgus wedged orthoses or orthotic device 10 is disclosed herein for use primarily with heeled shoes of more than 3 cm.
  • the orthotic device 10 can be used in other shoe types including sports, flat, sandal and dress shoes.
  • the orthotic device 10 concentrates the support under the lateral rearfoot, lateral midfoot and lateral forefoot, minimizing the degree of supination of the foot.
  • the biomechanical changes that occur by minimizing the degree of supination of the foot in a heeled shoe include stabilisation of the lateral ankle, unloading of the peroneal and lateral gastrocnemius musculature and reduced out-of-phase activation of the flexor and extensor musculature.
  • orthotics for heeled shoes feature support concentrated in the medial arch and some comprise of a varus wedge of the rearfoot and/or forefoot, potentially exacerbating the negative biomechanical changes associated with a heeled shoe.
  • the orthotic device 10 disclosed herein provides the opposite force to the foot, concentrating the support on the lateral foot to align the foot closely to neutral, preventing over supination and the associated biomechanical changes whilst in a heeled shoe.
  • the orthotic device 10 Whilst the orthotic device 10 concentrates the majority of support along the lateral border of the foot, the orthotic device 10 also includes a medial arch support 40 for the population of users that require medial longitudinal arch support whilst wearing a heeled shoe.
  • the vertical height of the medial arch contour or support 40 is not sufficiently large to apply a varus force to the foot and therefore will not exacerbate the negative biomechanical changes associated with a heeled shoe.
  • the orthotic device 10 is slim-line in profile with perimeter dimensions and shell thickness to fit tight fitting and narrow footwear that may be open toe, sling-back, open back, strapped or enclosed.
  • the orthotic device 10 includes a body portion or shell 25, providing a soft and flexible platform for supporting and cushioning the foot.
  • the medial arch contour 40 is soft and malleable to provide comfort and prevent over pronation of the foot in those consumers that require medial support.
  • the orthotic device 10 includes a valgus wedge 20 which supports the lateral foot to reduce the supinatory effect of the windlass mechanism whilst in a heeled shoe.
  • the valgus wedge 20 may be a lateral skive or alternatively an external valgus posting.
  • the orthotic device 10 may be used with shoes types including but not limited to heeled shoes (of varying vertical pitches), dress shoes, flat shoes, sandals, wedges and sports shoes.
  • the orthotic device 10 may be provided as an off-the-shelf orthotic device 10 which can be added to any appropriate footwear by the consumer.
  • the orthotic device 10 may be added during the shoe manufacturing process in replacement of the standard shoe liner (insole) and sold as an inclusion to the shoe.
  • the shape and contours of the orthotic device 10, the valgus wedge 20 extending from the rearfoot distally through to the forefoot as well as the medial arch contour 40, may be applied to form the shank of the heeled shoe during the manufacturing process.
  • the orthotic device 10 is depicted with a shell or body portion 25 having a thickness of approximately 1.5mm.
  • the body portion 25 tapers away around the anterior edge and medial side perimeters of the orthotic device 10.
  • the high, lateral side of the device 10 includes the valgus wedge 20 in addition to the 1.5mm body or shell 25 thickness that tapers from the lateral side to the medial side of the device 25. That is, a high point is defined by the orthotic tapering upwardly away from the body 25 portion at an angle of approximately 7 degrees (approximately 4.5mm total vertical height) however could be up to 20mm toward the lateral side.
  • the wedge 20 effect can best be seen in Fig, 2 , which shows the taper from the high, lateral side to the low medial side.
  • the decline from lateral to medial may be a consistent slant, may be stepped, or may be a combination of both.
  • Fig. 1 and Fig. 4 show a variation in gradual decline from the lateral side to the medial side.
  • the valgus wedge 20 or posting may be, though is not limited to, 7 degrees to 0 degrees, lateral to medial (equating to approx. 4.5mm of vertical height on the lateral border of the device, in addition to the 1.5mm body or shell 25 thickness of the device) however the vertical height on the lateral border of the device may be up to 20mm.
  • the orthotic device 10 includes medial arch support 40, as identified in Fig. 1 , and defined by the raise in height of the device 10 upwardly away from the body portion 25 into the space of the medial longitudinal arch of the foot.
  • the medial arch support defines a curved prominence or projection, as depicted in Figs. 1 and 2 .
  • the medial arch support 40 ascends gradually in height from posterior to anterior, with the highest point located at the approximate mid point of the arch before descending toward the anterior in a similar gradient. The height of the medial arch support 40 also descends laterally away from the medial side. Referring to Figs. 1 to 3 , the outline of the medial arch support 40 is shown.
  • the medial arch support 40 assists wearers who pronate.
  • Fig. 2 depicts a lateral perspective side view of the orthotic device 10.
  • the high point of the medial arch support 40 raises above the body portion 25.
  • the medial arch support 40 may be 20mm in height ( ⁇ 19mm).
  • a curved channel or depression 44 is located between the medial arch support 40 and the medial edge of the valgus wedge 20.
  • the presence of the channel 44 may be of benefit for the manufacturing process and/or marketing of the device to visually differentiate between the medial arch support 40 and the valgus wedge 20.
  • the orthotic device 10 may include a top cover or layer.
  • the top cover material will be evenly adhered across the entire dorsal surface of the orthotic device 10, thus not altering the overall wedge of the device and therefore this measurement is not included in the diagrams.
  • the orthotic device 10 may include an increase in height at the metatarsal arch region, to define a metatarsal support 60, beneath a metatarsal arch region of the foot.
  • Fig. 4 shows the area in which additional height extends upwardly, and congruently, from the body 25, locally eliminating the valgus wedge 20 at this point of the orthotic device 10.
  • the metatarsal support 60 also known as a metatarsal dome, raise or bar 60, and may be 6mm in height ( ⁇ 5.5mm) and taper down on each edge gradually to conjoin with the valgus wedge 20.
  • the orthotic device 10 may include a lateral arch support 50 (also referred to as a cuboid notch) that provides further lateral foot support in addition to the valgus wedge 20.
  • a lateral arch support 50 also referred to as a cuboid notch
  • the lateral arch support 50 is an area of additional height extending upwardly from the highest portion of valgus wedge 20, located at the position corresponding with the lateral longitudinal arch of the foot.
  • Figs. 1 and 2 show the valgus wedge 20 positioned laterally and superiorly to the low medial side. As shown in those figures, there is a wedge effect or tapering from the elevated, lateral side of the orthotic device 10 to the medial (reduced thickness) side.
  • Fig. 2 depicts a lateral side view of the orthotic device 10.
  • the high, lateral side of device 10 includes 7 degrees valgus wedge 20 (equating to approx. 4.5mm vertical height on the lateral border of the device) + 1.5mm shell thickness, however this angle may be increased (up to 20mm height) or decreased (to 2mm height) depending on the purpose of the device 10.
  • Fig. 2 also shows the outline of the medial arch support 40, positioned medially and superiorly to the lateral side of the device 10.
  • the orthotic device 10 addresses the over-supination of a user's foot whilst the ankle is positioned in a high degree of plantar flexion when wearing heeled shoes. Accordingly, the orthotic device 10 addresses the subsequent biomechanical changes that occur to the foot in the transverse and frontal planes (as identified above) whilst in a heeled shoe.
  • This design and concept may be used in further research, prescription of orthoses as well as the design and manufacture of footwear and off-the-shelf orthotic devices.
  • the orthotic device 10 concentrates the support under the lateral rearfoot, lateral midfoot and lateral forefoot with a valgus wedge 20 to balance the foot and ankle whilst in a heeled shoe.
  • the orthotic device 10 may be manufactured and sold as an orthotic device that is off-the-shelf, customized with additions or applicable during the footwear manufacturing process to be glued, adhered or sewn into the shoe during manufacturing.
  • the measurements are standardised to the size of a small orthotic device 10 and the measurements will either increase with larger sizes or decrease with smaller sizes.
  • the dimensions may be altered for a custom fit to the last. In this case it may replace the standard shoe liner and therefore the dimensions will extend to the perimeters of the shoe as per a standard shoe liner.
  • the orthotic device 10 for heeled, dress or flat shoe will be appropriately dimensioned for a narrow and shallow shoe.
  • the shell or body portion 25 may be manufactured from, but not limited to, open or closed cell polyethylene foam, open or closed cell polyurethane foam, cross linked polyethylene foam, EVA foam (Ethylene Vinyl Acetate), gel, silicon, polypropylene, or any other cellular rubber and/or foam material.
  • the shell 25, valgus wedge 20 and medial arch support 40 may be a combination of thickness, density and/or materials.
  • the top cover may be made from, but not limited to, open or closed cell polyurethane, open or closed cell polyethylene, foam materials, cellular rubbers, neoprene, nylon, vinyl, leather, gel and silicon.
  • the top cover may, or may not, extend the full length of the device 10.
  • the high point of the medial arch support 40 may be, but not limited to, 20mm ( ⁇ 19mm) and tapers away from the high point.
  • the lateral arch support 50 is an additional feature according to a preferred embodiment ( Fig. 4 ). It will be tapered around the perimeter and will be highest under a user's cuboid bone with the highest point measuring 3mm ( ⁇ 2mm). The lateral arch support 50 height is additional to the measurement of the valgus (lateral) wedge 20.
  • the valgus wedge 20 may extend from the rearfoot through to the forefoot, or may partially extend, or taper to reduce the valgus support, between the rearfoot and forefoot.
  • the valgus posting will be 0mm under the medial side of the 1st metatarsal head and extends transversely under the lateral side of the 5th metatarsal shaft to measure up to 20mm.
  • the heel cup height will be dictated by the valgus wedge 20 height on the lateral side (up to 20mm) and will be the minimal thickness of the shell on the medial side ( Fig 4 ).
  • the valgus wedge 20 of the orthotic 10 may taper longitudinally to zero under the toes ( Fig 1 ).
  • the shell 25 may include a 6mm ( ⁇ 5.5mm) high metatarsal support 60 located on the proximal edge of the 2nd, 3rd and 4th metatarsal heads.
  • the valgus wedge 20 significantly reduces the degree of foot supination caused by the plantar flexed position of the ankle whilst in a heeled shoe.
  • the orthotic device 10 improves the balance between the medial and lateral ankle stabilising musculature and reduces the activation of the secondary ankle stabilizers thus reducing the clawing effect of the toes.
  • the orthotic device 10 may experience less muscle fatigue, less pain, greater endurance, reduced lateral ankle instability and reduced likelihood of associated injuries such as falls, fractures, ligamentous strain, tendinopathies and soft tissue overuse associated with walking and standing in heeled shoes.
  • the orthotic device 10 reduces the degree of supination at the forefoot, midfoot and rearfoot by applying an angular force concentrated under the lateral forefoot, lateral midfoot and lateral rearfoot.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Claims (10)

  1. Orthetische Vorrichtung (10) zur Verwendung mit einem Absatz-, Gesellschafts-, Flach- oder Sportschuh, wobei die Vorrichtung umfasst:
    einen Körperabschnitt (25);
    eine durch einen sich nach oben vom Körperabschnitt (25) erstreckenden Vorsprung definierte Medialgewölbestütze (40); und
    einen durch einen an einem lateralen hinteren Fußabschnitt und/oder einem lateralen Mittelfußabschnitt und/oder einem lateralen Vorderfußabschnitt des Körperabschnitts (25) angeordneten Vorsprung definierten Valgus-Keil (20), wobei sich der Valgus-Keil (20) entlang eines seitlichen Rands der orthetischen Vorrichtung (10) vom hinteren Fußabschnitt zum Vorderfußabschnitt des Körperabschnitts (25) erstreckt, wobei sich der Valgus-Keil (20) von einer hohen lateralen Seite zu einer niedrigen medialen Seite des Körperabschnitts (25) verjüngt, wobei der Valgus-Keil (20) zum Auswärtsdrehen des Fußes und lateralen Konzentrieren der Stütze der Vorrichtung angepasst ist,
    wobei ein gekrümmter Kanal oder eine Vertiefung (44) zwischen der Medialgewölbestütze (40) und dem medialen Rand des Valgus-Keils (20) angeordnet ist.
  2. Orthetische Vorrichtung nach Anspruch 1, wobei der Valgus-Keil (20) bis zu 20 mm vertikale Höhe an der lateralen Seite der Vorrichtung in Bezug auf den Körperabschnitt (25) misst.
  3. Orthetische Vorrichtung (10) nach einem der vorhergehenden Ansprüche, wobei der Va-Igus-Keil (20) eine innen angeordnete laterale Ausschärfung ist.
  4. Orthetische Vorrichtung (10) nach Anspruch 1 oder 2, wobei der Valgus-Keil (20) eine äußere Valgus-Stütze ist.
  5. Orthetische Vorrichtung (10) nach einem der vorhergehenden Ansprüche, ferner umfassend eine durch einen sich vom Körperabschnitt (25) weg erstreckenden Vorsprung definierte Lateralgewölbestütze (50), wobei die Lateralgewölbestütze (50) an einem lateralen Abschnitt der Vorrichtung (10) am höchsten und zum Anordnen im Wesentlichen unter einem Würfelbein des Fußes eines Benutzers angepasst ist.
  6. Orthetische Vorrichtung (10) nach einem der vorhergehenden Ansprüche, ferner umfassend eine Mittelfußstütze (60).
  7. Orthetische Vorrichtung (10) nach einem der vorhergehenden Ansprüche, ferner umfassend eine Medialgewölbekontur von 20 mm +/-19 mm.
  8. Verfahren zum Anpassen einer orthetischen Vorrichtung (10) an einen Schuh, wobei das Verfahren den Schritt umfasst zum:
    Bemessen der orthetischen Vorrichtung (10), so dass eine Länge eines Körperabschnitts (25) der orthetischen Vorrichtung (10) im Wesentlichen einer Länge des Fußes eines Benutzers oder dem proximalen Abschnitt des Benutzerfußes entspricht;
    wobei die orthetische Vorrichtung (10) einen Valgus-Keil (20) umfasst, wobei sich der Va-Igus-Keil (20) entlang eines seitlichen Rands der orthetischen Vorrichtung (10) von einem hinteren Fußabschnitt zu einem Vorderfußabschnitt des Körperabschnitts (25) erstreckt, wobei sich der Valgus-Keil (20) von einer hohen lateralen Seite zu einer niedrigen medialen Seite verjüngt, wobei der Valgus-Keil (20) zum Auswärtsdrehen des Fußes und lateralen Konzentrieren der Stütze der Vorrichtung, um eine Konzentration der Stütze unter dem lateralen Fuß zum Verringern einer übermäßigen Supination zu erzielen, angepasst ist;
    wobei ein gekrümmter Kanal oder eine Vertiefung (44) zwischen der Medialgewölbestütze (40) und dem medialen Rand des Valgus-Keils (20) angeordnet ist.
  9. Verfahren nach Anspruch 8, ferner umfassend den Schritt zum Anordnen einer Lateralgewölbestütze (50), die sich nach oben vom Körperabschnitt (25) weg erstreckt, so dass ein hoher Punkt der Lateralgewölbestütze (50) im Wesentlichen unterhalb eines Würfelbeins des Fußes eines Benutzers angeordnet ist.
  10. Verfahren nach Anspruch 8 oder 9, wobei die orthetische Vorrichtung (10) im Schuh als Teil der Schaft- oder Innensohlengestaltung hergestellt wird.
EP16831985.3A 2015-08-05 2016-08-05 Orthetische vorrichtung für schuhe Active EP3331392B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2015903126A AU2015903126A0 (en) 2015-08-05 Orthotic device for shoes
PCT/AU2016/050709 WO2017020091A1 (en) 2015-08-05 2016-08-05 Orthotic device for shoes

Publications (3)

Publication Number Publication Date
EP3331392A1 EP3331392A1 (de) 2018-06-13
EP3331392A4 EP3331392A4 (de) 2019-03-20
EP3331392B1 true EP3331392B1 (de) 2020-04-15

Family

ID=57942127

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16831985.3A Active EP3331392B1 (de) 2015-08-05 2016-08-05 Orthetische vorrichtung für schuhe

Country Status (7)

Country Link
US (1) US20190021438A1 (de)
EP (1) EP3331392B1 (de)
CN (1) CN107920622A (de)
AU (1) AU2016303794B2 (de)
HK (1) HK1247052A1 (de)
NZ (1) NZ739391A (de)
WO (1) WO2017020091A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11350699B2 (en) * 2018-07-06 2022-06-07 Richard Kim Orthotic arch support device and method of use
US20220370230A1 (en) * 2018-07-06 2022-11-24 Richard Kim Orthotic arch support devices and methods of use
DE102018009107A1 (de) * 2018-11-21 2020-05-28 Jörg Hefft Vorrichtung zur Stimulation von Faszien
KR102202828B1 (ko) * 2018-11-29 2021-01-14 김일수 굽 높은 신발의 바닥구조물 및 이를 구비한 굽 높은 신발
USD936946S1 (en) * 2019-09-26 2021-11-30 Scholl's Wellness Company Limited Insole
US20220151814A1 (en) * 2020-11-18 2022-05-19 Kinetic Orthotics Pty Ltd Orthotics
CN115024552A (zh) * 2022-06-21 2022-09-09 广东足迹鞋业有限公司 一种孩童用矫正稳步鞋

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1516425A (en) * 1923-11-26 1924-11-18 Dvilnsky Abraham Innersole and method of making same
US2227429A (en) * 1938-10-31 1941-01-07 Dale W Austin Foot balancer for metatarsal and weak foot conditions
US3084695A (en) * 1961-08-01 1963-04-09 O'donnell Charles Edward Method of making arch supporting cushion innersole
US3135265A (en) * 1962-06-11 1964-06-02 Universal Stay Company Inc Foot cushioning device
GB1571127A (en) * 1976-04-02 1980-07-09 Scholl Uk Ltd Soles for footwear and footwear incorporating them
US7107705B2 (en) * 2002-12-23 2006-09-19 Spenco Medical Corporation Insole with improved cushioning and anatomical centering device
US4979318A (en) * 1988-05-02 1990-12-25 The Dr. Cohen Group, Inc. Pronatary insert for high-heeled shoes
US4955148A (en) * 1989-04-14 1990-09-11 Rigoberto Padilla Foot support assembly
CA2034300C (en) * 1990-02-16 1998-04-14 Dennis N. Brown Orthotic insert for shoes
US5063692A (en) * 1990-05-24 1991-11-12 Junko Suginaka Footwear and insole pad thereof
US5187885A (en) * 1990-07-19 1993-02-23 Murphy John T Golf shoe insert
US5625965A (en) * 1993-10-27 1997-05-06 Wolverine World Wide, Inc. Stand easy shoe insert
FR2765779B1 (fr) * 1997-07-11 1999-10-15 Catherine Atlani Semelle de relaxation et chaussure ainsi equipee
CA2231802A1 (en) * 1998-04-15 1999-10-15 Serge Brie An aerated cushioning structure with a variable density throughout
US6131311A (en) * 1998-04-17 2000-10-17 Payless Shoesource, Inc. Insole insert for footwear
US6286232B1 (en) * 2000-01-28 2001-09-11 Schering-Plough Healthcare, Inc. Pregnancy/maternity insoles
US6604301B1 (en) * 2000-07-10 2003-08-12 II Arthur Manoli Shoe sole insert
US6510626B1 (en) * 2000-07-28 2003-01-28 Kent S. Greenawalt Custom orthotic foot support assembly
US6871422B2 (en) * 2000-10-17 2005-03-29 Rhino Tuff, Inc. Protective, orthotic insert for footwear
US6725578B2 (en) * 2001-04-03 2004-04-27 D. Casey Kerrigan Joint protective shoe construction
US20070074430A1 (en) * 2003-09-20 2007-04-05 Coomer Sven O Orthotic device
US20060123664A1 (en) * 2003-10-14 2006-06-15 Boyd Robert E Insole having multiple energy sources
US20060000114A1 (en) * 2004-04-09 2006-01-05 Love Bethel W Heel balancing insole
US7284342B2 (en) * 2004-08-06 2007-10-23 Schering-Plough Healthcare Products, Inc. Heel insert
US7299568B2 (en) * 2004-09-15 2007-11-27 Tager Steven E Orthopedic foot devices
US20060059726A1 (en) * 2004-09-22 2006-03-23 Ching-Hui Song Foot orthosis
US7484319B2 (en) * 2005-08-12 2009-02-03 Spenco Medical Corporation Shoe insole
TWI289055B (en) * 2006-01-17 2007-11-01 Homeway Technology Co Ltd An insole and an orthopedic shoe
US8424222B2 (en) * 2007-11-21 2013-04-23 Spenco Medical Corporation Arthritis and diabetes insole
US20100269371A1 (en) * 2009-04-28 2010-10-28 Geoffrey Alan Gray Orthotic shoe insert for high-heeled shoes
US8667715B2 (en) * 2009-10-09 2014-03-11 Santtro, Llc Orthotic devices and methods for manufacturing same
MX2012013296A (es) * 2010-06-25 2013-01-24 Spenco Medical Corp Plantilla contorneada de soporte.
WO2014036176A1 (en) * 2012-08-31 2014-03-06 Spenco Medical Corporation Basketball insole
TWM466530U (zh) * 2013-06-28 2013-12-01 Jet Crown Internat Co Ltd 醫用矯正鞋墊結構

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
AU2016303794B2 (en) 2018-05-10
WO2017020091A1 (en) 2017-02-09
AU2016303794A1 (en) 2018-02-08
CN107920622A (zh) 2018-04-17
HK1247052A1 (zh) 2018-09-21
NZ739391A (en) 2023-06-30
EP3331392A1 (de) 2018-06-13
EP3331392A4 (de) 2019-03-20
US20190021438A1 (en) 2019-01-24

Similar Documents

Publication Publication Date Title
EP3331392B1 (de) Orthetische vorrichtung für schuhe
US10251443B2 (en) Device for three-dimensional foot motion control and plantar pressure redistribution
US8756836B2 (en) Foot support
US4517981A (en) Orthotic device
US8069586B2 (en) Orthopedic foot appliance
US9192502B2 (en) Ankle-foot orthotic
US7120958B2 (en) Mass producible custom-made shoe inserts
US20040103561A1 (en) Footwear with orthopedic component system
US20110099842A1 (en) Motion control insole with muscle strengthening component
US6026599A (en) Pseudo-planar insole insert
US7041075B2 (en) Orthotic foot devices for bare feet and methods for stabilizing feet
US20190133250A1 (en) Orthopedic insoles
CN209807256U (zh) 一种足跟痛鞋垫矫形器
US20200170825A1 (en) Footwear to correct pronation issues
KR101799579B1 (ko) 코리고 패턴을 유도하는 아웃솔
US20240188677A1 (en) Auxiliary or integrated inner sole structure for footwear
US12011066B2 (en) Shoe slide with podiatric elements
US20230338181A1 (en) Orthosis and method of use
KR101848900B1 (ko) 교정용 중창
US20180295931A1 (en) Corrective insole
NZ782459A (en) Improved Orthotics
Connors Walking and running
CN115024552A (zh) 一种孩童用矫正稳步鞋
CH623210A5 (en) Orthopaedic shoe
AU2021269382A1 (en) Improved Orthotics

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180215

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190218

RIC1 Information provided on ipc code assigned before grant

Ipc: A43B 17/02 20060101ALI20190212BHEP

Ipc: A43B 7/14 20060101ALI20190212BHEP

Ipc: A43B 7/24 20060101AFI20190212BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20191122

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016034235

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1256268

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200515

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20200415

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200817

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200715

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200716

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200815

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1256268

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200415

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200715

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016034235

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

26N No opposition filed

Effective date: 20210118

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200805

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200805

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200415

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230822

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230821

Year of fee payment: 8